Dr. Adit Mahale, MD (he/him) is a Nephrologist in Charlotte, NC with over 18 years of experience. What is your opinion of Dr. Adit Mahale, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Adit Mahale, MD has received over $3,373 which includes payments from the following companies:
$1,574.31 from Mallinckrodt LLC
$474.11 from Retrophin, Inc.
$400.00 from Questcor Pharmaceuticals
$221.52 from Otsuka America Pharmaceutical, Inc.
$125.00 from Alexion Pharmaceuticals, Inc.
$122.73 from Relypsa, Inc.
$99.99 from Mallinckrodt Enterprises LLC
$89.13 from Janssen Pharmaceuticals, Inc
$36.98 from Fresenius USA Marketing, Inc.
$36.23 from Veloxis Pharmaceuticals, Inc.
$31.33 from Baxter Healthcare
$21.81 from Otsuka Pharmaceutical Development & Commercialization, Inc.
$18.91 from Novartis Pharmaceuticals Corporation
$18.33 from OPKO Pharmaceuticals, LLC
$17.30 from Genentech USA, Inc.
$16.62 from Mallinckrodt Hospital Products Inc.
$15.12 from Keryx Biopharmaceuticals, Inc.
$14.68 from Astellas Pharma US Inc
$14.15 from Boehringer Ingelheim Pharmaceuticals, Inc.
$12.86 from Takeda Pharmaceuticals America, Inc.
Payments received by Dr. Adit Mahale, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!